Biotech Showcase™, the investor conference in San Francisco produced by Demy-Colton and EBD Group, is devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to investors and pharmaceutical exec
8th Microbiome Movement - Drug Development Summit Europe in Barcelona featuring industry leaders, technology showcase, networking opportunities, and transformative insights for drug development... ConferenceMedical & Pharma Interested 4Mon, 10 - Wed, 12 Mar 2025 International Summit on Biotechnology and ...
Beijing-headquartered GC-Rise, which focuses on women's health inChina, aims to take the opportunity to showcase its growth stories and seek tie-ups with potential partners to help them tapChina's growing healthcare market. The biotech conference is held fromJanuary 7-9inSan Francisco, Califor...
Dx&Vx CEO Kwon Kyu-chan Kwon presents at the Biotech Showcase in San Francisco, Calif. Dx&Vx said Monday that it has agreed to establish various types of cooperation through partnering meetings with about 30 companies, including global pharmaceutical companies, drug developers, and investment compa...
(94,715,599 shares outstanding, 11/1/11). $UGNE plans on presenting at Biotech Showcase next week, so we‘ll get an update on its plans for 2012. Any new program they announce will likely have several years ahead of developmental uncertainty, so buying now would be a stretch unless ...
Matica Biotechnology, the U.S. subsidiary of CHA Biotech, said Wednesday that it has secured multiple contracts with biotech firms, signaling growth for its contract development and manufacturing organization (CDMO) business. CHA Biotech is a Korean comp
Our marketplace is not just a showcase platform but also a collaborative space. Here, everyone can contribute their wisdom and share the agents they have developed.Tip By 🤖/🏪 Submit Agents, you can easily submit your agent creations to our platform. Importantly, LobeChat has established ...
A recent panel of experts argued that trends in big data will drive up its relevance and provide a navigable path toward greater utility both in pharma and in healthcare. The panelists at theworkshop I put together for the 2014 Biotech Showcase in San Franciscolast week hinted that the tim...
Shares of biotech firms specializing in stem cell therapies are performing well on KOSDAQ, despite the latest plunge of Cha Biotech, one of the promising biotech stocks. On Monday, stem cell therapy-related firms, including Corestem, Medipost, and Kangs